In vitro metabolite identification of ML3403, a 4-pyridinylimidazole-type p38 MAP kinase inhibitor by LC-Qq-TOF-MS and LC-SPE-cryo-NMR/MS

References

• Borlak J, Walles M, Elend M, Thum T, Preiss A, Levsen K. Verapamil: Identification of novel metabolites in cultures of primary human hepatocytes and human urine by LC-MS(n) and LC-NMR4. Xenobiotica 2004; 33: 655–76
   Google Scholar
• Caldwell GW, Ritchie DM, Masucci JA, Hageman W, Yan Z. The new pre-preclinical paradigm: Compound optimization in early and late phase drug discovery. Current Topics in Medicinal Chemistry 2001; 1: 353–366
   PubMedGoogle Scholar
• Cerecetto H, Gonzalez M, Seoane G, Stanko C, Piro OE, Castellano EE. Mass spectrometry of 1,2,5-oxadiazole N-oxide derivatives. Use of deuterated analogues in fragmentation pattern studies. Journal of the Brazilian Chemical Society (http://jbcs.sbq.org.br) 2004; 15: 232–240
   Google Scholar
• Chauret N, Gauthier A, Nicoll-Griffith DA. Effect of common organic solvents on in vitro cytochrome P450-mediated metabolic activities in human liver microsomes. Drug Metabolism and Disposition 1998; 26: 1–4
   PubMed Web of Science ®Google Scholar
• Chernushevich IV, Loboda AV, Thomson BA. An introduction to quadrupole-time-of-flight mass spectrometry 1. Journal of Mass Spectrometry 2001; 36: 849–865
   PubMed Web of Science ®Google Scholar
• Clarke NJ, Rindgen D, Korfmacher WA, Cox KA. Systematic LC/MS metabolite identification in drug discovery 1. Analytical Chemistry 2001; 73: 430A–439A
   PubMed Web of Science ®Google Scholar
• Clayton E, Taylor S, Wright B, Wilson ID. The application of high performance liquid chromatography, coupled to nuclear magnetic resonance spectroscopy and mass spectrometry (HPLC-NMR-MS), to the characterization of ibuprofen metabolites from human urine. Chromatographia 1998; 47: 264–270
   Web of Science ®Google Scholar
• Duckett CJ, Lindon JC, Walker H, bou-Shakra F, Wilson ID, Nicholson JK. Metabolism of 3-chloro-4-fluoroaniline in rat using [14C]-radiolabelling, 19F-NMR spectroscopy, HPLC-MS/MS, HPLC-ICPMS and HPLC-NMR. Xenobiotica 2006; 36: 59–77
   PubMed Web of Science ®Google Scholar
• Exarchou V, Godejohann M, van Beek TA, Gerothanassis IP, Vervoort J. LC-UV-solid-phase extraction-NMR-MS combined with a cryogenic flow probe and its application to the identification of compounds present in Greek oregano. Analytical Chemistry 2003; 75: 6288–6294
   PubMed Web of Science ®Google Scholar
• Foster ML, Halley F, Souness JE. Potential of p38 inhibitors in the treatment of rheumatoid arthritis. Drug News and Perspectives 2000; 13: 488–497
   PubMed Web of Science ®Google Scholar
• Godejohann M, Tseng LH, Braumann U, Fuchser J, Spraul M. Characterization of a paracetamol metabolite using on-line LC-SPE-NMR-MS and a cryogenic NMR probe. Journal of Chromatography. A 2004; 1058: 191–196
   PubMed Web of Science ®Google Scholar
• Hansen SH, Jensen AG, Cornett C, Bjornsdottir I, Taylor S, Wright B, Wilson ID. High-performance liquid chromatography on-line coupled to high-field NMR and mass spectrometry for structure elucidation of constituents of Hypericum perforatum L. Analytical Chemistry 1999; 71: 5235–5241
   Web of Science ®Google Scholar
• Kostiainen R, Kotiaho T, Kuuranne T, Auriola S. Liquid chromatography/atmospheric pressure ionization-mass spectrometry in drug metabolism studies. Journal of Mass Spectrometry 2003; 38: 357–372
   PubMed Web of Science ®Google Scholar
• Krauser JA, Voehler M, Tseng LH, Schefer AB, Godejohann M, Guengerich FP. Testosterone 1 beta-hydroxylation by human cytochrome P450 3A4. European Journal of Biochemistry 2004; 271: 3962–3969
   PubMedGoogle Scholar
• Kumar S, Boehm J, Lee JC. p38 MAP kinases: Key signalling molecules as therapeutic targets for inflammatory diseases. Nature Reviews. Drug Discovery 2003; 2: 717–726
   PubMed Web of Science ®Google Scholar
• Laufer SA, Wagner GK, Kotschenreuther DA, Albrecht W. Novel substituted pyridinyl imidazoles as potent anticytokine agents with low activity against hepatic cytochrome P450 enzymes. Journal of Medicinal Chemistry 2003; 46: 3230–3244
   PubMed Web of Science ®Google Scholar
• Lee JC, Kumar S, Griswold DE, Underwood DC, Votta BJ, Adams JL. Inhibition of p38 MAP kinase as a therapeutic strategy. Immunopharmacology 2000; 47: 185–201
   PubMed Web of Science ®Google Scholar
• Levsen K, Schiebel HM, Behnke B, Dotzer R, Dreher W, Elend M, Thiele H. Structure elucidation of phase II metabolites by tandem mass spectrometry: An overview. Journal of Chromatography. A 2005; 1067: 55–72
   PubMed Web of Science ®Google Scholar
• Lin JH, Lu AY. Role of pharmacokinetics and metabolism in drug discovery and development. Pharmacological Reviews 1997; 49: 403–449
   PubMed Web of Science ®Google Scholar
• March RE, Stadey CJ, Lewars EG. Pyridine N-oxide and pyridine-d5 N-oxide: An electrospray/tandem mass spectrometric study carried out at high mass resolution. Rapid Communications in Mass Spectrometry 2005; 19: 984–1004
   PubMedGoogle Scholar
• Mortishire-Smith RJ, O’Connor D, Castro-Perez JM, Kirby J. Accelerated throughput metabolic route screening in early drug discovery using high-resolution liquid chromatography/quadrupole time-of-flight mass spectrometry and automated data analysis 1. Rapid Communications in Mass Spectrometry 2005; 19: 2659–2670
   PubMed Web of Science ®Google Scholar
• Nyberg NT, Baumann H, Kenne L. Solid-phase extraction NMR studies of chromatographic fractions of saponins from Quillaja saponaria. Analytical Chemistry 2003; 75: 268–274
   PubMedGoogle Scholar
• Ojanpera S, Pelander A, Pelzing M, Krebs I, Vuori E, Ojanpera I. Isotopic pattern and accurate mass determination in urine drug screening by liquid chromatography/time-of-flight mass spectrometry 1. Rapid Communications in Mass Spectrometry 2006; 20: 1161–1167
   PubMed Web of Science ®Google Scholar
• Ono K, Han J. The p38 signal transduction pathway: Activation and function. Cell Signalling 2000; 12: 1–13
   PubMed Web of Science ®Google Scholar
• Pullen FS, Swanson AG, Newman MJ, Richards DS. ‘Online’ liquid chromatography/nuclear magnetic resonance mass spectrometry—a powerful spectroscopic tool for the analysis of mixtures of pharmaceutical interest. Rapid Communications in Mass Spectrometry 1995; 9: 1003–1006
   Web of Science ®Google Scholar
• Scarfe GB, Wright B, Clayton E, Taylor S, Wilson ID, Lindon JC, Nicholson JK. Quantitative studies on the urinary metabolic fate of 2-chloro-4-trifluoromethylaniline in the rat using 19F-NMR spectroscopy and directly coupled HPLC-NMR-MS. Xenobiotica 1999; 29: 77–91
   PubMed Web of Science ®Google Scholar
• Shockcor JP, Unger SE, Wilson ID, Foxall PJ, Nicholson JK, Lindon JC. Combined HPLC, NMR spectroscopy, and ion-trap mass spectrometry with application to the detection and characterization of xenobiotic and endogenous metabolites in human urine. Analytical Chemistry 1996; 68: 4431–4435
   PubMed Web of Science ®Google Scholar
• Spraul M, Freund AS, Nast RE, Withers RS, Maas WE, Corcoran O. Advancing NMR sensitivity for LC-NMR-MS using a cryoflow probe: Application to the analysis of acetaminophen metabolites in urine. Analytical Chemistry 2003; 75: 1536–1541
   PubMed Web of Science ®Google Scholar
• Wadsworth SA, Cavender DE, Beers SA, Lalan P, Schafer PH, Malloy EA, Wu W, Fahmy B, Olini GC, Davis JE, et al. RWJ 67657, a potent, orally active inhibitor of p38 mitogen-activated protein kinase. Journal of Pharmacology and Experimental Therapeutics 1999; 291: 680–687
   PubMed Web of Science ®Google Scholar
• Ward KW, Proksch JW, Gorycki PD, Yu CP, Ho MY, Bush BD, Levy MA, Smith BR. SB-242235, a selective inhibitor of p38 mitogen-activated protein kinase. II: In vitro and in vivo metabolism studies and pharmacokinetic extrapolation to man 3. Xenobiotica 2002; 32: 235–250
   PubMed Web of Science ®Google Scholar
• Wright P, Alex A, Gibson D, Jones R, Macrae P. Characterisation of sulphoxides by atmospheric pressure ionisation mass spectrometry. Rapid Communications in Mass Spectrometry 2005; 19: 2005–2014
   PubMedGoogle Scholar